Daiken Biomedical Co., Ltd.
Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd.
Daiken Biomedical Co., Ltd. (7780) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.006x
Based on the latest financial reports, Daiken Biomedical Co., Ltd. (7780) has a cash flow conversion efficiency ratio of 0.006x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$34.63 Million) by net assets (NT$5.35 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Daiken Biomedical Co., Ltd. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Daiken Biomedical Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Daiken Biomedical Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daiken Biomedical Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vinte Viviendas Integrales S.A.B. de C.V
MX:VINTE
|
-0.033x |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
0.037x |
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
0.074x |
|
Quoc Cuong Gia Lai JSC
VN:QCG
|
0.004x |
|
Easy Trip Planners Limited
NSE:EASEMYTRIP
|
0.008x |
|
Acme United Corporation
NYSE MKT:ACU
|
0.061x |
|
IPC
F:IPC
|
0.208x |
|
Singaraja Putra
JK:SINI
|
0.040x |
Annual Cash Flow Conversion Efficiency for Daiken Biomedical Co., Ltd. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Daiken Biomedical Co., Ltd. from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.31 Billion | NT$51.75 Million | 0.040x | -90.69% |
| 2023-12-31 | NT$247.32 Million | NT$105.20 Million | 0.425x | +132.66% |
| 2022-12-31 | NT$227.43 Million | NT$41.58 Million | 0.183x | -- |